News & Analysis on Clinical Trial Services & Contract Research And Development
A series of new drugs to treat HIV infection which work in different ways to available therapies are moving through clinical trials, raising the hope that a new generation of antivirals is on the horizon to treat resistant strains of the virus.
Eastman Chemical has extended its agreement with Johnson Matthey subsidiary Alfa Aesar in a move that will for the first time make its proprietary BoPhoz catalyst ligands available in research quantities.
Troubled chemicals company Rhodia has pressed ahead with plans to sell off its food ingredients portfolio, allowing it to focus on its core chemicals and pharmaceuticals businesses.
Germany's KGaA has announced plans to sell off its laboratory distribution business VWR International and operate as a smaller, higher-margin business focused on pharmaceuticals, chemicals and liquid crystals.
Mark McClellan, considered the most industry-friendly Commissioner that the US Food and Drug Administration has had in years, could be leaving his position before the end of the month, according to industry speculation.
UK tablet press and coating machine specialist Manesty will introduce another product in its Xpress range at the TOTAL 2004 show next month as it navigates the sea-change in its business that has emerged over the last few years.